“【Re

News Highlights

On March 18, 2026, PR TIMES reported on the holding of a free web seminar titled “Special Corporation M&A and Business Succession” Comparison & Case Study Seminar – Understanding the Differences from Business Companies.” This seminar will focus on the unique M&A and business succession schemes of special corporations, which differ from those of business companies (such as transfer of equity interests, changes in members, and refund of funds), and will explain them with case examples. For smooth business succession of medical institutions, appropriate corporate valuation that comprehensively assesses medical profits, fixed assets, licenses, staff, and patient base, as well as support for stable operation after the transaction, are essential.

M&A Medical Editorial Department’s Perspective

This seminar, “Special Corporation M&A and Business Succession,” includes several points that medical institution managers cannot afford to overlook. In particular, the fact that medical corporations, as “special corporations,” must adopt M&A schemes different from those of business companies highlights their complexity. For example, in medical corporations where the transfer of equity interests is not possible, more specialized knowledge and procedures are required, such as changing the representative director and directors through a resolution of the general meeting of members, or refunding funds. Furthermore, the valuation of intangible assets, not just medical profits, but also the patient base cultivated over many years, regional licenses, and the retention of excellent staff, is indispensable for an appropriate corporate valuation. M&A Medical (CentralMedience Inc.) provides comprehensive support, including post-transaction follow-up, on how to ensure the continuity of medical services and contribution to regional healthcare under the new system, not just the completion of the transaction.

Points Highlighted by This News

• Unlike business companies, medical corporations cannot transfer equity interests, so special succession schemes such as changes in members or refund of funds are central.
• The valuation of assets unique to medical institutions, such as patient base, licenses, and staff, in addition to medical profits, holds the key to M&A.
• Detailed M&A and business succession support by experts who understand the specific regulations and procedures for special corporations is essential.
• Smooth organizational operation and maintenance of the regional healthcare delivery system after the M&A transaction are important criteria for successful succession.

Practical Questions Arising from This News

• What procedures are necessary when resolving a change of representative director at a general meeting of members of a medical corporation?
• In M&A of a medical corporation without equity interests, how is the transfer price calculated?
• I am concerned that existing patients may leave after the M&A. What countermeasures can be considered?

If You Feel “Should I Consult Too?”

If your institution faces challenges such as its management status or lack of successors, and there are specific restrictions for special corporations, such as the inability to transfer equity interests or difficulty in changing members, utilizing M&A advisors with specialized knowledge is essential. By consulting with experts well-versed in M&A and business succession for medical institutions, such as those mentioned in this seminar (e.g., M&A Medical Co., Ltd. CentralMedience), you can identify the optimal scheme for your institution, achieve an appropriate corporate valuation, and gain a clear path towards smooth business succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a business succession support institution certified by the Small and Medium Enterprise Agency, on a full success fee basis. Consultations are accepted with strict confidentiality. Free consultation here